Stock ELVN ENLIVEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Real-time Estimate Cboe BZX
Other stock markets
 01:53:14 2024-05-20 pm EDT 		5-day change 1st Jan Change
23.5 USD +1.97% Intraday chart for Enliven Therapeutics, Inc. -3.96% +69.94%
May. 14 Enliven Therapeutics Q1 Loss Narrows MT
Apr. 11 Enliven Therapeutics, Inc. Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
AQ
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
AQ
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
AQ
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
AQ
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
AQ
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
AQ
Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
AQ
Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
AQ
Enliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
AQ
Enliven Therapeutics : Material Agreement - Form 8-K
PU
Enliven Therapeutics : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K
PU
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. News Enliven Therapeutics, Inc.
  5. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW